BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26215294)

  • 1. Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice?
    Glaser SL; Clarke CA; Keegan TH; Chang ET; Weisenburger DD
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1474-88. PubMed ID: 26215294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin's disease.
    Medeiros LJ; Greiner TC
    Cancer; 1995 Jan; 75(1 Suppl):357-69. PubMed ID: 8001007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of classic and nodular lymphocyte predominant hodgkin lymphoma in Finland in 1996-2015.
    Juntikka T; Malila N; Ylöstalo T; Merikivi M; Jyrkkiö S
    Acta Oncol; 2020 May; 59(5):574-581. PubMed ID: 31910680
    [No Abstract]   [Full Text] [Related]  

  • 4. Expert review of the diagnosis and histologic classification of Hodgkin disease in a population-based cancer registry: interobserver reliability and impact on incidence and survival rates.
    Glaser SL; Dorfman RF; Clarke CA
    Cancer; 2001 Jul; 92(2):218-24. PubMed ID: 11466672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006.
    van Leeuwen MT; Turner JJ; Joske DJ; Falster MO; Srasuebkul P; Meagher NS; Grulich AE; Giles GG; Vajdic CM
    Int J Cancer; 2014 Nov; 135(9):2146-56. PubMed ID: 24639369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between ambient ultraviolet radiation and Hodgkin lymphoma subtypes in the United States.
    Bowen EM; Pfeiffer RM; Linet MS; Liu WT; Weisenburger DD; Freedman DM; Cahoon EK
    Br J Cancer; 2016 Mar; 114(7):826-31. PubMed ID: 26889979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of classical Hodgkin lymphoma and its association with Epstein Barr virus in Northern China.
    Huang X; Nolte I; Gao Z; Vos H; Hepkema B; Poppema S; van den Berg A; Diepstra A
    PLoS One; 2011; 6(6):e21152. PubMed ID: 21695175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin lymphoma: clinicopathologic features in Benin City, Nigeria and update on its biology and classification.
    Olu-Eddo AN; Omoti CE
    Niger J Clin Pract; 2011; 14(4):440-4. PubMed ID: 22248946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin lymphoma incidence in California Hispanics: influence of nativity and tumor Epstein-Barr virus.
    Glaser SL; Clarke CA; Chang ET; Yang J; Gomez SL; Keegan TH
    Cancer Causes Control; 2014 Jun; 25(6):709-25. PubMed ID: 24722952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
    Milano AF
    J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.
    Gordon-Dseagu VL; Devesa SS; Goggins M; Stolzenberg-Solomon R
    Int J Epidemiol; 2018 Apr; 47(2):427-439. PubMed ID: 29149259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
    Ali S; Olszewski AJ
    Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups.
    Allemani C; Sant M; De Angelis R; Marcos-Gragera R; Coebergh JW;
    Cancer; 2006 Jul; 107(2):352-60. PubMed ID: 16770772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hodgkin's lymphoma in the biopsy material. A retrospective analysis (author's transl)].
    Wöckel W; Rüdiger KD
    Zentralbl Allg Pathol; 1982; 126(1-2):123-32. PubMed ID: 7090591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
    Gerber NK; Atoria CL; Elkin EB; Yahalom J
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Childhood Hodgkin Lymphoma in Mexico by Histologic Subtypes and Socioeconomic Regions.
    Rendón-Macías ME; Valencia-Ramón EA; Fajardo-Gutiérrez A; Castro-Ríos A
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):e97-e101. PubMed ID: 26535773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease in Greece: a retrospective clinicopathologic study of 78 cases.
    Floros D; Papakyriazis N; Boutis L; Symeonidis A
    J Surg Oncol; 1982 Jun; 20(2):119-23. PubMed ID: 7078192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease in American Negroes. Histologic classification of the disease in 143 untreated patients, and age distribution.
    Olisa EG; Kennedy J; Kish MH; Lanava TS; Williams AO
    Am J Clin Pathol; 1976 Sep; 66(3):537-44. PubMed ID: 961633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical Profile of Hodgkin and Non-Hodgkin Lymphoma.
    Shahid R; Gulzar R; Avesi L; Hassan S; Danish F; Mirza T
    J Coll Physicians Surg Pak; 2016 Feb; 26(2):103-7. PubMed ID: 26876395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.